ng-nitroarginine methyl ester has been researched along with Parkinson Disease, Secondary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amorim, EDT; Crestani, CC; de Jager, L; Lopes, FNC; Lucchetti, BFC; Martins-Pinge, MC; Pinge-Filho, P | 1 |
| Dragunow, M; MacGibbon, G; Walton, M; Woodgate, A | 1 |
| Barthwal, MK; Dikshit, M; Srivastava, N | 1 |
3 other study(ies) available for ng-nitroarginine methyl ester and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Nitric oxide alterations in cardiovascular system of rats with Parkinsonism induced by 6-OHDA and submitted to previous exercise.
Topics: Animals; Arterial Pressure; Cardiovascular System; Dopamine; Enzyme Inhibitors; Heart Rate; Male; Neostriatum; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidopamine; Parkinson Disease, Secondary; Physical Conditioning, Animal; Rats; Rats, Wistar; Tissue Distribution | 2018 |
The toxicity of 6-hydroxydopamine on PC12 and P19 cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aurintricarboxylic Acid; Biological Transport; Bisbenzimidazole; Carrier Proteins; Cell Membrane; Desipramine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluorescent Dyes; Free Radical Scavengers; In Situ Nick-End Labeling; Melatonin; Membrane Glycoproteins; Membrane Transport Proteins; Necrosis; Nerve Tissue Proteins; Neurons; NG-Nitroarginine Methyl Ester; Oxidopamine; Parkinson Disease, Secondary; PC12 Cells; Rats; Sympatholytics; Tretinoin; Tritium | 1999 |
Role of nitric oxide in a progressive neurodegeneration model of Parkinson's disease in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Animals; Corpus Striatum; Disease Models, Animal; Disease Progression; Dopamine; Enzyme Inhibitors; Homovanillic Acid; Male; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley | 2001 |